Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $640.66 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $178.63 | 13 | $0 (2020) |
| Amgen Inc. | $169.13 | 11 | $0 (2020) |
| Lilly USA, LLC | $157.52 | 11 | $0 (2019) |
| Cleerly, Inc. | $84.95 | 1 | $0 (2023) |
| SANOFI PASTEUR INC. | $17.27 | 1 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $16.96 | 1 | $0 (2017) |
| Boston Scientific Corporation | $16.20 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $84.95 | 1 | Cleerly, Inc. ($84.95) |
| 2020 | $60.74 | 4 | Novo Nordisk Inc ($30.19) |
| 2019 | $168.19 | 10 | Amgen Inc. ($92.87) |
| 2018 | $125.61 | 9 | Lilly USA, LLC ($44.57) |
| 2017 | $201.17 | 15 | Lilly USA, LLC ($86.16) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2023 | Cleerly, Inc. | Cleerly Labs (Device) | Food and Beverage | In-kind items and services | $84.95 | General |
| 06/29/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Bone Health | ||||||
| 05/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 02/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 01/10/2020 | SANOFI PASTEUR INC. | ADACEL (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Vaccines | ||||||
| 11/22/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Bone Health | ||||||
| 10/25/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 09/13/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.19 | General |
| 09/06/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Bone Health | ||||||
| 06/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 06/07/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Bone Health | ||||||
| 05/24/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 03/29/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Bone Health | ||||||
| 02/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 01/11/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Bone Health | ||||||
| 06/20/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Endocrinology | ||||||
| 05/14/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 05/06/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 04/16/2018 | Boston Scientific Corporation | GENERAL VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: VASCULAR | ||||||
| 04/02/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Endocrinology | ||||||
| 03/11/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 02/19/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 02/04/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Diabetes | ||||||
| 01/08/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 12/04/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,328 | 3,258 | $417,335 | $95,604 |
| 2022 | 12 | 1,187 | 2,982 | $339,615 | $75,119 |
| 2021 | 15 | 1,259 | 3,010 | $334,516 | $93,675 |
| 2020 | 17 | 1,515 | 3,277 | $354,963 | $90,136 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,621 | $93,778 | $29,162 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 353 | $114,017 | $18,296 | 16.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 125 | 125 | $58,323 | $9,764 | 16.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 167 | 167 | $54,044 | $8,758 | 16.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $17,883 | $6,487 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 140 | $30,990 | $5,394 | 17.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 70 | 70 | $13,440 | $5,035 | 37.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 351 | 554 | $8,310 | $4,654 | 56.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $6,845 | $2,612 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $2,800 | $2,062 | 73.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 19 | $9,310 | $1,434 | 15.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 15 | $2,475 | $649.65 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $880.00 | $647.90 | 73.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 40 | $2,400 | $445.85 | 18.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 23 | $1,840 | $203.71 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 304 | 466 | $146,240 | $24,179 | 16.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 1,320 | $72,600 | $22,010 | 30.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 91 | 91 | $38,178 | $6,152 | 16.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 79 | 79 | $13,430 | $5,415 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $27,778 | $5,266 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 84 | $17,943 | $3,865 | 21.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $5,426 | $2,475 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 81 | $3,240 | $2,295 | 70.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 386 | 703 | $10,545 | $2,082 | 19.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $800.00 | $571.31 | 71.4% |
About Dr. Carl Meyer, MD
Dr. Carl Meyer, MD is a Internal Medicine healthcare provider based in Media, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215945985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Meyer, MD has received a total of $640.66 in payments from pharmaceutical and medical device companies, with $84.95 received in 2023. These payments were reported across 39 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($640.66).
As a Medicare-enrolled provider, Meyer has provided services to 5,289 Medicare beneficiaries, totaling 12,527 services with total Medicare billing of $354,534. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Media, PA
- Active Since 08/04/2006
- Last Updated 08/06/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215945985
Products in Payments
- TRULICITY (Drug) $144.28
- Ozempic (Drug) $94.61
- Cleerly Labs (Device) $84.95
- Prolia (Biological) $83.21
- EVENITY (Biological) $72.53
- Saxenda (Drug) $38.74
- Victoza (Drug) $21.81
- ADACEL (Biological) $17.27
- SOLIQUA (Drug) $16.96
- GENERAL VASCULAR INTERVENTION (Device) $16.20
- BASAGLAR (Drug) $13.24
- Xultophy 100/3.6 (Drug) $12.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Media
Rajesh Patel, Md, MD
Internal Medicine — Payments: $116,429
George Lieb, Md, MD
Internal Medicine — Payments: $105,199
Daniel Soffer, Md, MD
Internal Medicine — Payments: $61,441
Benjamin Jacobs, Md, MD
Internal Medicine — Payments: $27,401
Leemu Kerkula, M.d, M.D
Internal Medicine — Payments: $11,422
Dr. Ezekiel Adewale, D.o, D.O
Internal Medicine — Payments: $11,030